The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
On Tuesday, Riverside County received 690 vials of the monkeypox vaccine from the California Department of Public Health. But as monkeypox cases continue to grow in the Coachella Valley, there’s not ...
First human DNA vaccine First in class thermostable self-amplifying mRNA vaccine GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges ...
LUBBOCK, Texas (KCBD) - A new medical technology development called microneedles could change the way we receive vaccines. The band-aid-like patch gets coated in the vaccine and is applied to the skin ...
People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique. The FDA issued an ...
The new intradermal technique requires just a fraction of a vaccine per shot. Some states and jurisdictions are hitting early bumps in their rollout of the U.S. government's new approach to expand ...
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its needle-free injection technology, will present at the American Society of Tropical Medicine and ...
Hi, it’s Dong in London. Supplies of the world’s only approved vaccine for monkeypox are running low, and countries from the US to the UK recommend stretching available doses by using intradermal ...
The transition from Monkeypox Inoculation Plan A to Monkeypox Inoculation Plan B has been a smashing success—at least, if you ask federal officials. Just a few weeks ago, the U.S. had nowhere near ...
PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...
PharmaTher Holdings PHRRF, the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study ...
NanoPass Technologies Ltd., a global leader in intradermal delivery solutions, will officially launch MicronJet™ 800 during IMCAS World 2026, taking place January 29 – 31, 2026, in Paris.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results